TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06385691

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myDIET software tool
Description: The tool is based on self-questionnaires completed by the patient. They are mainly filled in using visual analogue scales (from 0-10) or grades of symptoms/toxicities (Grades 0 to 4), based on the CTCAE V5. These scales will cover the following themes: food intake, weight changes, digestive symptoms, taste disorders, pain and fatigue. The system will be able to monitor data changes and the response given will be adapted according to the severity of symptoms:~* No signs of seriousness: general prevention or treatment documents/advice: toxicity management, nutritional advices targeted on symptoms, on digestive problems, on appropriate physical activity.~* Presence of signs of seriousness: action to be taken and alert to the coordinating nurse, oncologist or dietician.~In case of an alert, the coordinating nurse will call the patient back and either manage the symptom, schedule a nutritional consultation to initiate nutritional management, or refer the patient to the oncologist.
Study: NCT05062824

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baby Feed
Description: Baby Feed web portals can (1) Quickly and easily evaluate infant diet using a validated Infant Food Frequency Questionnaire (infant FFQ) developed by our group14. \[Parental FFQ portal\]; (2) Provide automatic results to healthcare professionals on nutrients and foods/beverages consumed above or below the recommended levels to discuss with parents for improving the infant's diet. Also, to provide recommendations for amounts of foods/beverages that the infant should be consuming by age \[Clinician Portal\]; (3) Give online access to parents to these diet recommendations to implement at home, with an easy tracking component \[Parent's Portal\].
Study: NCT05581472

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online Acceptance and Commitment Therapy Intervention + Phone Coaching
Description: The intervention has 8 modules. The modules Away Moves and Letting Go of Control, help to establish creative hopelessness, where one abandons futile struggles against negative internal experiences and accepts new solutions. These two modules also help identify experiential avoidance and focus on acceptance. The modules Noticing Hooks and Stepping Back focus on diffusion, self as context, and mindfulness. While mindfulness is overtly addressed in the module Stepping Back, it is weaved through each module. The modules Your Values and How You Want to Act focus on helping participants identify their values. The modules Goal Setting and Making Commitments focus on committed action. Each module has a practice assignment which participants are asked to engage in over the next week.~During the phone coaching calls, the participant will be able to troubleshoot any technical difficulties and ask any questions about the material being taught in the intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online Acceptance and Commitment Therapy Intervention without phone coaching
Description: The intervention has 8 modules. The modules Away Moves and Letting Go of Control, help to establish creative hopelessness, where one abandons futile struggles against negative internal experiences and accepts new solutions. These two modules also help identify experiential avoidance and focus on acceptance. The modules Noticing Hooks and Stepping Back focus on diffusion, self as context, and mindfulness. While mindfulness is overtly addressed in the module Stepping Back, it is weaved through each module. The modules Your Values and How You Want to Act focus on helping participants identify their values. The modules Goal Setting and Making Commitments focus on committed action. Each module has a practice assignment which participants are asked to engage in over the next week.
Study: NCT05661630

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EDUCATION AND COUNSELING WITH EX-PLISSIT MODEL
Description: In addition to the routine procedure, the women in the experimental group of the research will be given sexual education and counseling with the EX-PLISSIT model. The steps to be followed in accordance with this model are as follows; Session 1 Permission Limited Information The Specific Suggestions The IT-Intensive Therapy Session 2 At the beginning of the interview, the data forms will be reapplied, and then the homework given in the first session will be discussed. The information that the patient needs in line with his questions will be given within the steps of the Ex-PLISSIT model, within the steps of allowing, limited information, special recommendations and, if necessary, intensive therapy.~Session 3 At the beginning of the interview, the data forms will be applied for the last time and the patient's questions, if any, will be answered and the session will be ended.
Study: NCT05990192

Intervention type: DRUG
Group type: OTHER
Intervention: Niraparib oral capsule
Description: Niraparib used following SBRT treatment until disease progression

Intervention type: RADIATION
Group type: OTHER
Intervention: SBRT
Description: SBRT may be delivered using a specialist SBRT platform, such as CyberKnife or with a linear accelerator with SBRT capabilities.

Intervention type: RADIATION
Group type: OTHER
Intervention: SBRT
Description: SBRT may be delivered using a specialist SBRT platform, such as CyberKnife or with a linear accelerator with SBRT capabilities.
Study: NCT05595564

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy
Description: A previous application of photobiomodulation therapy was offered or not, for possible performance enhancement.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Photobiomodulation therapy
Description: A previous application of photobiomodulation therapy was offered or not, for possible performance enhancement.
Study: NCT04788225

Intervention type: OTHER
Intervention: Balance assessment
Description: Static balances will be measured with the Biodex-BioSway 950-462 static balance device according to 3 different standard test procedures (Postural Stability Test, Stability Limit Test and Modified Sensori Organization Test) in single foot stance and double foot stance.~Dynamic balances will be evaluated with the Y balance test.

Intervention type: OTHER
Intervention: Balance assessment
Description: Static balances will be measured with the Biodex-BioSway 950-462 static balance device according to 3 different standard test procedures (Postural Stability Test, Stability Limit Test and Modified Sensori Organization Test) in single foot stance and double foot stance.~Dynamic balances will be evaluated with the Y balance test.

Intervention type: OTHER
Intervention: Functionality assessment
Description: Functionality will be evaluated with the Lower Extremity Functional Scale and AOFAS (American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale)

Intervention type: OTHER
Intervention: Functionality assessment
Description: Functionality will be evaluated with the Lower Extremity Functional Scale and AOFAS (American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale)

Intervention type: OTHER
Intervention: Performance assessment
Description: Performance evaluation will be made with a single leg jump test and time up and go test.

Intervention type: OTHER
Intervention: Performance assessment
Description: Performance evaluation will be made with a single leg jump test and time up and go test.

Intervention type: OTHER
Intervention: ROM assessment
Description: Range of motion (ROM) of the ankle will be measured with an electrogonyometer in dorsi-plantar flexion.

Intervention type: OTHER
Intervention: ROM assessment
Description: Range of motion (ROM) of the ankle will be measured with an electrogonyometer in dorsi-plantar flexion.
Study: NCT05870449

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tunneled PICC
Description: Tunneled PICC is a type of PICC catheterization technique that involves establishing a subcutaneous tunnel to keep the outlet of the catheter away from the puncture site

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: routine PICC
Description: Peripherally inserted central venous catheterization is a technique that involves inserting PICC through the peripheral vein and infusing drugs into the central vein through a catheter.
Study: NCT06547242

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxin
Description: Single-dose administration of 600 mcg of Levothyroxin for the assessment of bioequivalence

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levothyroxin
Description: Single-dose administration of 600 mcg of Levothyroxin for the assessment of bioequivalence
Study: NCT05447767

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: KIT BMAC AND at-SVF FIDIA
Description: intra-articular infiltration or intra-articular and intra-osseous infiltration

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: KIT BMAC AND at-SVF FIDIA
Description: intra-articular infiltration or intra-articular and intra-osseous infiltration

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: KIT BMAC AND at-SVF FIDIA
Description: intra-articular infiltration or intra-articular and intra-osseous infiltration

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: KIT BMAC AND at-SVF FIDIA
Description: intra-articular infiltration or intra-articular and intra-osseous infiltration
Study: NCT06041425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: The patients were given 0.1mg/kg oxycodone 15 minutes before transcatheter arterial chemoembolization (TACE). WBC count, neutrophil percentage, CRP, and IL-6 were used as inflammatory markers and measured before TACE (1 day before TACE) and 24 hours after TACE. Assess pain and side effects during TACE and within 24 hours after TACE. Pain was evaluated using the 11 point Numeric Rating Scale (NRS).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sufentanil
Description: The patients were given 0.1μg/kg sufentanil 15 minutes before transcatheter arterial chemoembolization (TACE). WBC count, neutrophil percentage, CRP, and IL-6 were used as inflammatory markers and measured before TACE (1 day before TACE) and 24 hours after TACE. Assess pain and side effects during TACE and within 24 hours after TACE. Pain was evaluated using the 11 point Numeric Rating Scale (NRS).
Study: NCT05878821

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shockwave
Description: Shockwave therapy session once a week for month 1000shock per session

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shockwave
Description: Shockwave therapy session once a week for month 1000shock per session
Study: NCT04643418

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MPB-1734
Description: Administered once daily in a 21-day cycle
Study: NCT04751773

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Perioperative exercise training
Study: NCT05451433

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saccharomyces Boulardii 250 MG
Description: Normagut capsule twice a day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule twice a day
Study: NCT05170503

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab 200mg iv drip. Qd D1 + Oxaliplatin 130/m2 iv drip. Qd D1 + Tegafur (Gimeracil and Oteracil Potassium Capsules) \[40mg/m2 if BSA \<1.25m2, 50mg/m2 if BSA ≥1.25m2 \& \<1.5m2, 60mg/m2 if BSA ≥1.5m2\] po. Bid D1-14 for three cycles
Study: NCT05487287

Intervention type: DEVICE
Intervention: Kinematic computational analysis of the hand (Leap Motion device)
Description: Kinematic computational analysis exercises:~1. Finger extension~2. Wrist extension~3. Finger separation~4. Finger clamp

Intervention type: DEVICE
Intervention: Kinematic computational analysis of the hand (Leap Motion device)
Description: Kinematic computational analysis exercises:~1. Finger extension~2. Wrist extension~3. Finger separation~4. Finger clamp
Study: NCT05906212

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior lens capsule
Description: This group will be undergoing nonpenetrating deep sclerectomy and phacoemulsification with autotransplantation of anterior lens capsule.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-penetrating deep sclerectomy and phacoemulsification
Description: This group will be undergoing nonpenetrating deep sclerectomy and phacoemulsification alone.
Study: NCT05269212

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care trajectory
Description: Usual care after Spinal Cord Stimulation implantation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A biopsychosocial rehabilitation program
Description: A personalized biopsychosocial rehabilitation program specifically targeting return to work.
Study: NCT05811052

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suboccipital Release Technique
Description: The suboccipital release technique was applied to the participants in the experimental group by an experienced practitioner who had received osteopathy training. The individual lay in the supine position, and the practitioner applied the relaxation technique by placing his hands on the patient's nape-atlantooccipital joint. The application was continued until the relaxation of the muscles under the hand of the practitioner.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Suboccipital Release
Description: The participants in the control group were given a sham application by touching the hands of the therapist on the nape of the neck and waiting for a while.
Study: NCT06298513

Intervention type: OTHER
Intervention: Cardiac rehabilitation
Description: Six weeks of cardiac rehabilitation with physical training
Study: NCT05084365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulforaphane
Description: Sulforaphane is a compound that can be extracted from broccoli, Brussel sprouts, cabbage, and other cruciferous plants.
Study: NCT05275751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRPA1-inhibitor
Description: Pharmacological inhibition of TRPA1 during intradermal injection of hot synthetic interstitial fluid

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRPA1-inhibitor
Description: Pharmacological inhibition of TRPA1 during intradermal injection of hot synthetic interstitial fluid
Study: NCT05084365

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06505915

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pre op Carbohydrate drink
Description: Lemon flavoured clear carbohydrate drink

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clear fluid as per sip til send policy
Description: clear fluid such as water
Study: NCT05964114

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: Initial dosing based on (a combinations of) pharmacokinetic models tailored to the individual patient. Dose adjustment starting dose (within registered dosing range).
Study: NCT05596500

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Blueberry-protein gel
Description: Sport gel with blueberry extract and plant protein.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Blueberry gel
Description: Sport gel with blueberry extract only.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sport gel without the blueberry extract polyphenols and without protein.
Study: NCT05487378

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: PKU GOLIKE
Description: AA protein Substitute for the dietary management of PKU, PKU GOLIKE is a food for special medicinal purposes (FSMP) for the dietary management of PKU.

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: PKU GOLIKE
Description: AA protein Substitute for the dietary management of PKU, PKU GOLIKE is a food for special medicinal purposes (FSMP) for the dietary management of PKU.
Study: NCT05149378

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax combined with azacitidine regimen
Description: Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-21); azacitidine 75 mg/m2 subcutaneously once daily on days 1-7 .
Study: NCT05249127

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 64Cu-SAR-bisPSMA
Description: 64Cu-SAR-bisPSMA
Study: NCT06622213

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mucoadhesive film with Acmella oleracea extract
Description: Apply 1 patch on ulcer 3 times per day (after meals)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide 0.1% Oromucosal Paste
Description: Apply ¼ inch on ulcer 3 times per day (after meals)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: mucoadhesive film without Acmella oleracea extract
Description: Apply 1 patch on ulcer 3 times per day (after meals)
Study: NCT06051474

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Product
Description: Adults will receive a 2-week supply of nicotine patches to place on skin (14mg or 21mg; dosing depending on tobacco use per package insert) and oral nicotine mini-lozenges (2mg, 4mg, dosing depending on tobacco use per package insert). All participants will also receive a single smoking cessation counseling session with a physician. Surveys will be completed pre-intervention, within 24 hours of hospital discharge, and 2-weeks after hospital discharge.
Study: NCT04980651

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Remote ischemic conditioning
Description: Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mm Hg.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham remote ischemic conditioning
Description: Sham remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mm Hg.
Study: NCT05818358

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: black beans
Description: ¾ cup of cooked black beans

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: wheat berries
Description: ¾ cup of cooked whole wheat grain

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: white rice
Description: ¾ cup of cooked white rice
Study: NCT06642311

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Empty bladder group
Description: Patients in the empty bladder group will be instructed to empty the bladder immediately before the procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is empty. All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bladder distension group
Description: Patients in the bladder distension group will be instructed to drink one liter of water and to avoid urination during a period of 2 h before the scheduled procedure. A colleague will perform transabdominal ultrasound to confirm that the bladder is distended . All the procedures will be performed using the vaginoscopic technique. A rigid 2.9-mm hysteroscope with a 30° lens and a 5-mm outer sheath (Karl Storz GmbH, Tuttlingen, Germany) will be used in all procedures.
Study: NCT06025253

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy
Description: Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Wound Dressing
Description: Application of standard wound dressing post major lower extremity amputation
Study: NCT05565144

Intervention type: OTHER
Intervention: None, pure observational study
Description: None, pure observational study
Study: NCT05988905

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: robot assited gati training
Description: SUBAR® (CRETEM, Korea) is a exoskeletal-robot with a footplate that assists gait movements. The patient's thigh length and lower leg length were measured before training, so that the SUBAR® can be adjusted to patient's size to ensure accurate training. During training, the therapist facilitated the treatment and stood by the patients' side to adjust the direction and speed. RAGT is programmed automatically, and it can be performed regularly over a long period. The patients received 30 min of robot-assisted training using SUBAR® once a day for 5 days a week for 8 weeks. Each training session lasted up to 40 min.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional traiing
Description: Patients also received conventional exercise rehabilitation with the same duration and frequency. Conventional rehabilitation therapy, which consisted of active assistive knee exercises, knee stretching, patellar mobilization exercises, and quadriceps setting exercises, was performed every day throughout the rehabilitation period.
Study: NCT05570851

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alcohol Cessation Text Messages
Description: Intervention condition will consist of a text message program designed to promote alcohol cessation tailored to HNC patients and targeted to VA or Civilian populations in addition to usual-care-advice.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Control condition will consist of a provider-delivered alcohol cessation intervention with usual-care-advice.
Study: NCT06643767

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bexa and focus ultrasound
Description: The Bexa exam uses pressure elastography to produce a map of the breast tissue's elasticity to identify any masses. Focused ultrasound is then used to further classify the mass into a BIRADS category.
Study: NCT05814042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Next Generation ORS (oral rehydration solution) (including placebo
Description: Nutrition used to stop diarrhea

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Current standard control ORS (oral rehydration solution)
Description: current standard control ORS in diarrheic patients with cholera